Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.6M | $53.6M | $53.6M | $59.7M | $95.9M | $119.6M | $149.3M | $139.9M |
| Cost of revenue | $38.3M | $56.5M | $46.4M | $55.8M | $66.6M | $82.9M | $117.8M | $132.6M |
| Gross profit | $19.4M | −$2.9M | $7.2M | $3.9M | $29.3M | $36.6M | $31.5M | $7.3M |
| Gross margin | 33.6% | -5.5% | 13.5% | 6.6% | 30.6% | 30.6% | 21.1% | 5.2% |
| R&D | $28.3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$28.3M | −$20.6M | −$5.6M | −$10.6M | $8.9M | $10.9M | −$2.6M | −$18.7M |
| EBITDA | $3.8M | −$16.8M | −$2.6M | −$7.4M | $15.7M | $19.9M | $10.9M | −$11.5M |
| Net income | −$28.2M | −$21.8M | −$4.2M | −$7.3M | $11.2M | $127.7M | $560.0K | −$140.8M |
| Net margin | -48.9% | -40.7% | -7.9% | -12.2% | 11.7% | 106.8% | 0.4% | -100.6% |
| EPS (diluted) | -0.76 | -0.46 | -0.08 | -0.13 | 0.06 | 1.81 | 0.01 | -2.23 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $225M | $0.18 | $0.18–$0.18 | 1 |
| 2028 | $255M | $0.00 | $0.00–$0.00 | 0 |
| 2029 | $283M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds CDMO.
No tracked institution reports a position in CDMO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2017-07-10 | 1-for-7reverse |
No one on the platform has traded CDMO yet.
| $633M |
| — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
| ICPTIntercept Pharmaceuticals, Inc. | $19.00 | +0.21% | $795M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 5.6× sales vs its 7.3× historical median P/S.
Fair value ≈ $16.23 · price $12.49 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$INBS : Redefining the Future of Drug Screening Intelligent Bio Solutions is a diagnostics technology company advancing drug testing with a proprietary, non-invasive fingerprint sweat analysis platform, delivering fast, hygienic results as an alternative to traditional urine and saliva testing. 📈 Recent Milestones & Key Catalysts: INBS continues to execute on its growth strategy with several notable developments: 🥇FDA 510(k) submission, positioning the company for entry into the U.S. market 🥈Expansion of manufacturing capacity through a strategic global partner, improving scalability and margins 🥉Latest company update reporting approximately $13.78M in total assets versus $5.45M in total liabilities ➡️A growing commercial footprint with over 450 customers across 24 countries ➡️Ongoing innovation initiatives aimed at expanding non-invasive biosensing applications Communicated Disclaimer: http://stockresearchtoday.com/transforming-d… Sector Peers: $MRNA $CRSP $GILD $CDMO
View on StockTwits ↗$OLB $OLB hanging at support like $CDMO did before explosive breakouts.
View on StockTwits ↗@xmf2220 reminds me of what happened to $CDMO insuders bought the doom and gloom and made a good ROI when they got taken. I
View on StockTwits ↗@Taurusthebullman lol how low can this go? How much lower can my avg be? Sooner or later boom ! Looks like a avid $cdmo buyout coming
View on StockTwits ↗@Techallure Someone Manipulated Sale Of $CDMO And Stole It And This Patent From StockHOLDers! Patent Expiration Now Revised To: "Status-Active, 2038-05-30 Adjusted expiration" Per Google, The Current Assignees: "Oncxerna Therapeutics Inc Avid Bioservices Inc" And We Know Oncxerna Became Oncologie And Is Now Defunct, Which Means Avid's New Owners Retain 100% Of Patent. Also, USPTO.gov Shows NO RESULTS FOUND When Searching For Patent US20180289771A1, Avid Bioservices, OR Bavituximab. So, The Apparent Theft Seems Complete... (All in my humble opinion). Glta Retail Stock Investors In Future Investments!
View on StockTwits ↗$CDMO StockHOLDers: Looks Like Today's The Day! Schwab Issued My Cash For CDMO Stock. Glt You All...
View on StockTwits ↗$CDMO After Decades of suffering with the company changing from TCLN, to PPHM, then CDMO, the shareholders get screwed just as the business model is taking off. 🤬
View on StockTwits ↗What Happens IF Shorts Cover Before EndOfDay? Will The PPS Go up, Up, UP,...? Or Have The Shorters Already Arranged To Cover "Off Market", Behind Closed Doors? Fintel Still Shows 124% Owned By Institutional Investors!?!? https://fintel.io/so/us/cdmo Glta $CDMO StockHOLDers!
View on StockTwits ↗I Would Pay Good Money To See If Any Of The Numerous Existing Shorted Shares Of $CDMO Directly Or Indirectly Belonged To ANYONE Profiting From What Seems Like The Organized Stealing Of This Company! Glta...
View on StockTwits ↗Link To $CDMO News Release Regarding Today's Sale... https://ir.avidbio.com/news-releases/news-release-details/avid-stockholders-approve-transaction-gho-and-ampersand Glta Soon To Be ExStockHOLDers!
View on StockTwits ↗@jbraun123 So, I'm guessing that means 3 business days to finalize $CDMO sale? So, Fri, Mon, Tues? Thanks for the info!
View on StockTwits ↗@jbraun123 Yes, I attended the call/remote shareholder meeting via the link I posted this morning. $CDMO will post an audio replay in 24hrs(?) glty...
View on StockTwits ↗An Audio Replay Will Be Available In 24hrs(?)... At Either The Link I Previously Posted This Morning Or: https://www.virtualshareholdermeeting.com/CDMO2025SM Glta $CDMO Retail Investors...
View on StockTwits ↗Well $CDMO Folks, Sale Officially Approved. They Did Say If Approved, The Sale Would Be Finalized As Soon As Possible, Though They Didn't Elaborate On What That Meant: Hours, Days, Weeks, Etc... It Was Nice Knowing You All. Best Wishes For A Happy, Healthy, Wealthy 2025!
View on StockTwits ↗$CDMO Here's Link To Today's Stockholder Meeting Showing Vote... https://central.virtualshareholdermeeting.com/vsm/web?pvskey=CDMO2025SM Meeting Is At 10am PST/1pm EST It Asks For Your Accounts "Control Number" But, Will Probably Allow For Anonymous Login. Glta StockHOLDers!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.